The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the use of testosterone therapy in healthy women. Although the FDA approved testosterone therapy for the treatment of diseases affecting the testes, pituitary and hypothalamus, it hasn't been approved for treating age-associated decrease in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the security of testosterone. The study involved approximately 800 older men with low testosterone and symptoms related to this affliction, like testosterone therapy side effects
sexual and physical dysfunction. The research is expected to shed more light on the security of testosterone treatment since the men's heart health was carefully tracked.
The recent contradictory findings on testosterone treatment prompted his team to run a sizeable systematic literature
search for studies assessing the relationship between testosterone replacement therapy and cardiovascular events among men and Patel. An estimated 13 million men in the USA suffer from low testosterone, which happens when the body fails to make enough hormones because of a difficulty
with the testicles or pituitary gland. This explains obvious aging, a person's unexpected weight gain and loss of energy.
No clear lower limit of testosterone was established; nevertheless 15 ng per dL (0.5 nmol per L) usually is used. One study 38 found that women with 0 to 10 ng per dL (0 to 0.3 nmol per L) had markedly decreased sexual desire in all situations and absent or markedly reduced orgasms. Because of studies like this, supplemented with anecdotal evidence, many girls are started on testosterone treatment. Most girls can expect to spend one third of their lives in the postmenopausal period. Depression, anger, moodiness, insomnia, and lack of well-being are common criticisms of postmenopausal women.